Accelerating In Vivo CAR T-cell Development Case Study

This case study discusses the research conducted by Dr. Raymond Schiffelers at UMC Utrecht, focusing on the acceleration of in vivo CAR T-cell development. The study outlines the innovative approaches being developed for the delivery of CAR T cells, specifically through non-viral methods combined with DNA- and RNA-transposase technologies. It identifies the challenges faced in detecting cargo, delivery, integration, and translation, which are crucial for improving screening efficiency and optimizing construct design. The document presents a solution involving protein barcoding technology, which allows for the rapid and cost-effective tracking of multiple lipid nanoparticle (LNP) and CAR constructs. This method facilitates the efficient tracking of functional delivery, providing an alternative to traditional mass spectrometry techniques. The case study emphasizes the importance of optimizing various parameters in nanoparticle design to enhance the effectiveness of CAR T-cell therapies.